| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Jan 25 | ALXO ALX Oncology | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.65 | 600,000 | 990.00 k | 600,000 |
| 22 Mar 24 | CBAY Cymabay Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 20,125 | 0.00 | 0 |
| 22 Mar 24 | CBAY Cymabay Therapeutics | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 22.85 | 74,750 | 1.71 mm | 0 |
| 22 Mar 24 | CBAY Cymabay Therapeutics | Employee Stock Option Common Stock | Sale back to company | Dispose D | No | No | 8.76 | 360,000 | 3.15 mm | 0 |
| 24 Jan 24 | CBAY Cymabay Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 20,125 | 0.00 | 20,125 |
| 24 Jan 24 | CBAY Cymabay Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 22.85 | 74,750 | 1.71 mm | 74,750 |
